Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (5) | Back to Search
DESIGN AND SYNTHESIS OF NEW SULFAMATE DERIVATIVES AS POTENTIAL STEROID SULFATASE ENZYME INHIBITORS
- At: AbuDhabi (United Arab Emirates) (2019)
- Type: Poster
- Poster code: POS-DDD-003
- By: EL-GAMAL, Mohammed (United Arab Emirates)
- Co-author(s): Mohammed El-Gamal: Department of Medicinal Chemistry, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates
Seyed-Omar Zaraei: Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates
Paul Foster: Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates;, Institute of Metabolism and Systems Research, University of Birmingham, Birmingham B15 2TT, United Kingdom, Birmingham, United Kingdom
Raafat El-Awady: DEPARTMENT OF PHARMACY PRACTICE AND PHARMACOTHERAPEUTICS, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates
Barry Potter: DEPARTMENT OF PHARMACY PRACTICE AND PHARMACOTHERAPEUTICS, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates;Department of Pharmacology, University of Oxford, Oxford, United Kingdom - Abstract:
Background
The steroid sulfatase (STS) enzyme catalyzes the hydrolysis of inactive sulfate metabolites such as estrone sulfate and dehydroepiandrosterone sulfate to the more active estrone and dehydroepiandrosterone, respectively. Thus, STS is an attractive target for the treatment of hormone-dependent breast, endometrial,prostate cancers, and
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023